Welcome to our dedicated page for BESPOKE EXTRACTS news (Ticker: BSPK), a resource for investors and traders seeking the latest updates and insights on BESPOKE EXTRACTS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BESPOKE EXTRACTS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BESPOKE EXTRACTS's position in the market.
Bespoke Extracts has received approval from the Colorado Marijuana Enforcement Division for its application for "Suitability," allowing it to acquire licensed cannabis operations across Colorado. This approval is crucial for advancing its acquisitions of WonderLeaf, an infused products manufacturer, and Best Day Ever, a vertically integrated licensee. Both acquisitions remain pending final state and local regulatory approvals. This step positions Bespoke to expand its operations and enhance its product offerings significantly.
Bespoke Extracts, Inc. (OTCQB: BSPK) announced a definitive agreement to acquire the assets of Osiris, LLC, operating as Best Day Ever, in an all-stock transaction. This strategic move aims to enhance Bespoke's growth within the Colorado cannabis market by integrating a top-tier cultivator and retailer. Upon closing, Bespoke will issue 125 million shares, with 50% locked for six months. The deal is expected to close in Q4 2022, contingent on regulatory approvals. The acquisition will enable the relocation of BDE's Aspen dispensary and fortify Bespoke's cultivation capabilities.
Bespoke Extracts, Inc. (OTC: BSPK) announced its uplisting from the OTC Pink Open Market to the OTCQB Venture Market, effective May 10, 2022. This transition aims to enhance visibility and trading liquidity for retail and institutional investors. Recognized by the SEC, the OTCQB requires ongoing compliance with financial reporting and operational standards. CEO Michael Feinsod highlighted this milestone as a significant step towards transparency and growth, with plans for regular updates to shareholders.
Bespoke Extracts, Inc. (OTC: BSPK) announced its acquisition of Wonderleaf, LLC, a licensed marijuana infused products manufacturer in Colorado, for approximately $225,000, entirely in common shares. This transaction marks Bespoke’s entry into the regulated cannabis market, capitalizing on the $2.5 billion Colorado cannabis market. Bespoke plans to leverage Wonderleaf's award-winning products and aims to launch additional extraction products post-acquisition. The deal has been approved by Bespoke's board and awaits regulatory approvals for closure.
Bespoke Extracts, Inc. (OTC Pink: BSPK) has partnered with LEAF411™, a nonprofit nurse-staffed hotline, to provide its customers with reliable information on the safe use of hemp-derived CBD products. LEAF411 aims to educate the public about legal cannabis. This collaboration underscores Bespoke's commitment to quality, safety, and customer service. CEO Danny Pollack stated that this partnership affirms Bespoke's high standards and presents a valuable resource for customers seeking guidance on CBD use.
Bespoke Extracts (OTC Pink: BSPK) has appointed professional MMA fighter Mike 'Platinum' Perry as a brand ambassador to enhance brand awareness and credibility for its hemp-derived CBD products. With a notable social media following, Perry highlights the effectiveness of the products in his training regimen. Additionally, the company is now accepting pre-orders for its new Manuka Honey + CBD product line, with shipments expected by March 30, 2021. The focus on high-quality formulations aims to bolster the company’s market position.
Bespoke Extracts, Inc. (OTC Pink: BSPK) has successfully closed a private placement, issuing 10 million shares of common stock at $0.05 per share for total gross proceeds of $500,000. The funds will be utilized for working capital. CEO Danil Pollack emphasized that this investment bolsters the company's strategy to capture a larger market share in the growing hemp-derived CBD sector. The securities sold are unregistered under the Securities Act, limiting their offering without proper registration or exemption.
Bespoke Extracts, Inc. (OTC Pink: BSPK) has appointed Carly Stojsic as the new Director of Marketing. With 15 years of experience in trend forecasting and brand marketing, Stojsic will oversee all marketing strategies under CEO Danny Pollack. Her previous work includes positions with WGSN and major brands like Gucci and Starbucks. Pollack expressed confidence that Stojsic's expertise will enhance brand awareness and solidify Bespoke's position in the CBD market. The company emphasizes a commitment to safe and effective hemp-derived products.
FAQ
What is the current stock price of BESPOKE EXTRACTS (BSPK)?